Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 24:14:1421542.
doi: 10.3389/fonc.2024.1421542. eCollection 2024.

Editorial: PET/CT and MRI in prostate cancer

Affiliations
Editorial

Editorial: PET/CT and MRI in prostate cancer

Fabio Grizzi et al. Front Oncol. .
No abstract available

Keywords: MRI; PET/CT; artificial intelligence; diagnosis; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
The diagnostic pathway for PCa strives to achieve timely identification of clinically significant PCa while minimizing the detection of insignificant cases. This approach seeks to strike a balance between diagnostic accuracy and the potential burden on individuals and healthcare providers. Utilizing artificial intelligence, we integrate data from various scales (A) to enhance the diagnosis and treatment of prostate cancer. Within the collected dataset, the AI-driven system identifies and extrapolates the features and data points most pertinent to generating the ultimate outcome (B). The integration of diverse data and features culminates in a refined categorization of the condition (C), emphasizing that integration involves intricate connections among diverse characteristics observed across multiple scales, rather than a mere summation of individual outcomes.

Comment on

  • Editorial on the Research Topic PET/CT and MRI in prostate cancer

Similar articles

Cited by

References

    1. Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. . Eau-eanm-estro-esur-isup-siog guidelines on prostate cancer-2024 update. Part i: Screening, diagnosis, and local treatment with curative intent. Eur Urol. (2024). doi: 10.1016/j.eururo.2024.03.027 - DOI - PubMed
    1. Albright F, Stephenson RA, Agarwal N, Teerlink CC, Lowrance WT, Farnham JM, et al. . Prostate cancer risk prediction based on complete prostate cancer family history. Prostate. (2015) 75:390–85. doi: 10.1002/pros.22925 - DOI - PMC - PubMed
    1. Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, et al. . Mri-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med. (2020) 382:917–285. doi: 10.1056/NEJMoa1910038 - DOI - PMC - PubMed
    1. Liu J, Cundy TP, Woon DTS, Lawrentschuk N. A systematic review on artificial intelligence evaluating metastatic prostatic cancer and lymph nodes on psma pet scans. Cancers (Basel). (2024) 16. doi: 10.3390/cancers16030486 - DOI - PMC - PubMed
    1. Pinsky PF, Parnes H. Screening for prostate cancer. N Engl J Med. (2023) 388:1405–145. doi: 10.1056/NEJMcp2209151 - DOI - PubMed

Publication types

LinkOut - more resources